Pharmacokinetic Study of Oral Ɛ-Aminocaproic Acid in the Northern Elephant Seal
- Lungworm
- Pharmacokinetics
Abstract
ϵ-Aminocaproic acid (EACA) is a lysine analogue antifibrinolytic drug used to treat bleeding disorders in humans and domestic animals. Its use in zoological medicine is rare, and dosage is anecdotal. One possible application of EACA is to treat bleeding associated with prepatent Otostrongylus arteritis in Northern elephant seals (Mirounga angustirostris) presenting to wildlife rehabilitation centers. This study used an in vitro model of hyperfibrinolysis and a thromboelastograph-based assay to estimate the therapeutic plasma concentration of EACA in elephant seals (85 μg/ml, 95% confidence interval = 73.8–96.8 μg/ml). A concurrent pharmacokinetic study of orally administered, single-dose EACA found that doses of 75 and 100 mg/kg achieved therapeutic plasma concentrations (>85 μg/ml), but the drug was rapidly eliminated and remained in the therapeutic range for only 0.4 and 1.5 hr, respectively. Models of repeated oral dosing at 100 mg/kg every 6 hr predict that therapeutic plasma concentration will be maintained for 31.7% (7.6 hr) of a 24-hr period. More frequent dosing would be required to maintain continuous therapeutic concentrations but would be impractical in a wildlife rehabilitation setting. Further pharmacodynamic studies to evaluate the duration of action of EACA in elephant seals and a prospective, placebo-controlled study are needed to determine if EACA is effective in decreasing bleeding associated with prepatent Otostrongylus arteritis and other bleeding disorders in this species.
Kaye, S., Johnson, S., Arnold, R.D., Nie, B., Davis, J.T., Gulland, F., Abou-Madi, N., Fletcher, D.J. 2016. Pharmacokinetic study of oral Ɛ-Aminocaproic acid in the Northern elephant seal (Mirounga angustirostris). Journal of Zoo and Wildlife Medicine. 47(2): 438-446.
Related Publications
{"image":"\/Animals\/Patients\/California sea lions\/cropped-images\/csl-by-bill-hunnewell-c-the-marine-mammal-center-3-2-318-2819-2252-1600897445.jpg","alt":"California sea lion","title":"Establishing Dosing Requirements for an Anti-Fungal Medication in Young Sea Lions","link_url":"https:\/\/www.marinemammalcenter.org\/publications\/establishing-dosing-requirements-for-an-anti-fungal-medication-in-young-sea-lions","label":"Research Paper"}
Establishing Dosing Requirements for an Anti-Fungal Medication in Young Sea Lions
Read More{"image":"\/Animals\/Patients\/Steller sea lions\/2021\/cropped-images\/ssl-colby-by-bill-hunnewell-c-the-marine-mammal-center-522-282-2488-1943-1625764944.jpg","alt":"Steller sea lion Colby","title":"Field Anesthesia of Juvenile Steller Sea Lions Using Inhalation Anesthesia","link_url":"https:\/\/www.marinemammalcenter.org\/publications\/field-anesthesia-of-juvenile-steller-sea-lions-using-inhalation-anesthesia","label":"Research Paper"}
{"image":"\/Animals\/Patients\/Harbor seals\/2025\/cropped-images\/barrens-hs-photo-by-clive-beavis-c-the-marine-mammal-center-92-0-1270-992-1766172380.jpg","alt":"Pacific harbor seal","title":"Population pharmacokinetics of a single oral dose of gabapentin identifies rapid plasma clearance in rehabilitated Pacific harbor seal pups","link_url":"https:\/\/www.marinemammalcenter.org\/publications\/population-pharmacokinetics-of-a-single-oral-dose-of-gabapentin-identifies-rapid-plasma-clearance-in-rehabilitated-pacific-harbor-seal-pups","label":"Research Paper"}
Population pharmacokinetics of a single oral dose of gabapentin identifies rapid plasma clearance in rehabilitated Pacific harbor seal pups
Read MoreRecent News
{"image":"\/Animals\/Patients\/Harbor seals\/2020\/cropped-images\/hs-barnwood-by-bill-hunnewell-c-the-marine-mammal-center-315-0-3299-2577-1607370547.jpg","alt":"harbor seal Barnwood","title":"Last-Minute Gift Guide \u2013 Top Gifts that Give Back to Marine Animals","link_url":"https:\/\/www.marinemammalcenter.org\/news\/last-minute-gift-guide","label":"News Update","date":"2025-12-18 01:00:00"}
Last-Minute Gift Guide – Top Gifts that Give Back to Marine Animals
December 18, 2025
Read More{"image":"\/Animals\/Patients\/Hawaiian monk seals\/2025\/cropped-images\/b-ru72admission-to-ke-kai-ola112125photo-c-the-marine-mammal-center-noaa-permit-24359-0-364-1270-992-1766095407.jpg","alt":"A newborn Hawaiian monk seal pup with a black coat in rehabilitative care.","title":"Newborn Hawaiian Monk Seal Pup Now Receiving Care","link_url":"https:\/\/www.marinemammalcenter.org\/news\/newborn-hawaiian-monk-seal-pup-now-receiving-care","label":"Patient Update","date":"2025-12-18 01:00:00"}
{"image":"\/Animals\/Patients\/Hawaiian monk seals\/2025\/cropped-images\/d-ru28release-exam-at-ke-kai-ola111025photo-by-giancarlo-rulli-c-the-marine-mammal-center-noaa-permit-24359-0-0-1270-992-1764620886.jpg","alt":"","title":"Bird Flu Vaccine Trial Offers Hope for Protecting Hawaiian Monk Seals","link_url":"https:\/\/www.marinemammalcenter.org\/news\/bird-flu-vaccine-trial-may-offer-hope-for-protecting-hawaiian-monk-seals","label":"News Update","date":"2025-12-01 08:13:00"}
Bird Flu Vaccine Trial Offers Hope for Protecting Hawaiian Monk Seals
December 1, 2025
Read More{"image":"\/Animals\/Patients\/Hawaiian monk seals\/2021\/hms-pp08-by-sheila-latta-c-the-marine-mammal-center-noaa-permit-18786.jpg","alt":"Hawaiian monk seal","title":"The New York Times: Inside the Bird-Flu Vaccine Trial for Monk Seals","link_url":"https:\/\/www.marinemammalcenter.org\/news\/the-new-york-times-inside-the-bird-flu-vaccine-trial-for-monk-seals","label":"In the News","date":"2025-12-01 01:00:00"}
The New York Times: Inside the Bird-Flu Vaccine Trial for Monk Seals
December 1, 2025
Read More